GGrantIndex
← Search

SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS

$4,317M01FY2007RRNIH

Boston University Medical Campus, Boston MA

Investigators

Linked publications & trials

View original record on NIH RePORTER →